Careers  |  Sign In  |  Register  |   Twitter

New Multiple Sclerosis Drug Approved by FDA

A new article in The New York Times reports “A chemical once used to treat sofas — until it was found to cause rashes and blisters in people who sat on them — is now poised to become a major therapy for multiple sclerosis [MS].” The drug, called Tecfidera, was approved by the FDA for treatment of multiple sclerosis. While many MS treatments are injectable and reduce flare-up of symptoms only 30%, Tecfidera is an oral pill and “cut the relapse rate 44 percent in one trial and 53 percent in another.”

Read it in The New York Times.